Terminated NA INTERVENTIONAL 2-arm NCT02345096

Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis

A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis

Sponsor: Eurofins Optimed

Conditions Vulvo-vaginal Candidiasis

Interventions Placebo Saccharomyces cerevisiae

Updated 5 times since 2017 Last updated: Dec 2, 2016 Started: Jan 31, 2015 Primary completion: Jun 30, 2015 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruitment difficulties

Other terminated trials from Eurofins Optimed

More terminations from Eurofins Optimed

Listed as NCT02345096, this NA trial focuses on Vulvo-vaginal Candidiasis and remains terminated or withdrawn. Sponsored by Eurofins Optimed, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eurofins Optimed
Lesaffre International

Data source: Lesaffre International

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gières, France